Advertisement

Reactions Weekly

, Volume 1766, Issue 1, pp 262–262 | Cite as

Secukinumab

Ulcerative colitis and Crohn's disease: 4 case reports
Case report
  • 13 Downloads

Reference

  1. Fries W, et al. Inflammatory Bowel Disease Onset During Secukinumab Treatment: Real Concern or Just an Expression of Dysregulated Immune Response?. Clinical Drug Investigation 39: 799-803, No. 8, Aug 2019. Available from: URL: http://doi.org/10.1007/s40261-019-00803-7 - Italy

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations